Sagent Pharma launches generic form of Levaquin theflyonthewall
On Thursday July 7, 2011, 4:07 pm EDT
Sagent Pharmaceuticals announced the launch of levofloxacin injection in 5% dextrose, the generic form of the antibacterial Levaquin, in three ready-to-use premix bag strengths. According to 2010 IMS data, the U.S. market for levofloxacin approximated $156M.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.